Chil020 really appreciate your comments.Long term investors we are but these milestones i believe are real and obviously are due in due course, nasdaq listing probably some news on phase2b trials more so on safety which is huge as recently i think it was celldex that got suspended after a safety issue, US investors(im sure there will be atleast a few from DNDN) and other unexpected announcements. These milestones on a journey will r-rate this stock as it is being de-risked. Note there is risk.
Sourthern cross-equities are reputable and have a history of picking winners. I know they have had that buy from over a year ago but i think management took a bit long on deliverying of a few announcements example phase2b trial commencement was late. I think they are spot on for May 2011 there recommendation time. We are not ramping we are just suggesting our personal views on events which are due and are assuming that the share price will be affected one way or another. Goodluck to all. Especially if they keep coming up with really good announcements.
Only my opinion please do your own research.
Ann: AGM Presentation , page-26
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128197 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |